The company has provided various bio-medical therapeutics.
SEWONCELLONTECH is a bio-engineering company based in Seoul, Korea.
The company has provided various bio-medical therapeutics based on cellular and tissue engineering technologies as a key player in the bio-medical field.
SEWONCELLONTECH currently accelerates to market regenerative medicine therapies of cartilage, bone, skin, fat and UCB stem cells with innovative RMS -¡°Regenerative Medical System¡± to hospitals or laboratories where advanced regenerative therapeutics are needed. The company is publicly listed in Korean stock market (KOSPI) and employs in excess of 550 people in Korea, U.K., China and USA.
RMS is designed to enable hospitals to fully effectuate production of cell therapy products under the most advanced and stable system.
Since ¡®Tissue Engineering Research Group¡¯ was founded, the company has been actively dedicated to
develop and commercialize advanced regenerative medical therapies. RMS (Regenerative Medical System) is a total solution of regenerative medical practices
providing RM Platform of modulized facility and essential equipment, CE marked RM Kits of
consumables, and optimal operating program including technology of human cell treatment in cartilage,
bone, fat, skin and UCB therapy.
With these efforts to regenerative therapeutics, the company has also been focusing on the
development and marketing of ¡®atelocollagen¡¯ through the technology of sourcing and manufacturing
highly purified atelocollagen as a biocompatible material which can be applied into various
biomedical fields. It is manufactured in class 100 clean room of outstanding processing environment
with GMP facility.
The product-line related to atelocollagen covers dermal filler, hemostatic and wound healed form matrix
and gel skin protective cosmetics.
